333 related articles for article (PubMed ID: 21156285)
1. Loss of ATM/Chk2/p53 pathway components accelerates tumor development and contributes to radiation resistance in gliomas.
Squatrito M; Brennan CW; Helmy K; Huse JT; Petrini JH; Holland EC
Cancer Cell; 2010 Dec; 18(6):619-29. PubMed ID: 21156285
[TBL] [Abstract][Full Text] [Related]
2. ATM regulates ATR chromatin loading in response to DNA double-strand breaks.
Cuadrado M; Martinez-Pastor B; Murga M; Toledo LI; Gutierrez-Martinez P; Lopez E; Fernandez-Capetillo O
J Exp Med; 2006 Feb; 203(2):297-303. PubMed ID: 16461339
[TBL] [Abstract][Full Text] [Related]
3. Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner.
Hirao A; Cheung A; Duncan G; Girard PM; Elia AJ; Wakeham A; Okada H; Sarkissian T; Wong JA; Sakai T; De Stanchina E; Bristow RG; Suda T; Lowe SW; Jeggo PA; Elledge SJ; Mak TW
Mol Cell Biol; 2002 Sep; 22(18):6521-32. PubMed ID: 12192050
[TBL] [Abstract][Full Text] [Related]
4. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.
Smith J; Tho LM; Xu N; Gillespie DA
Adv Cancer Res; 2010; 108():73-112. PubMed ID: 21034966
[TBL] [Abstract][Full Text] [Related]
5. Role of ATM and the damage response mediator proteins 53BP1 and MDC1 in the maintenance of G(2)/M checkpoint arrest.
Shibata A; Barton O; Noon AT; Dahm K; Deckbar D; Goodarzi AA; Löbrich M; Jeggo PA
Mol Cell Biol; 2010 Jul; 30(13):3371-83. PubMed ID: 20421415
[TBL] [Abstract][Full Text] [Related]
6. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis.
Falck J; Mailand N; Syljuåsen RG; Bartek J; Lukas J
Nature; 2001 Apr; 410(6830):842-7. PubMed ID: 11298456
[TBL] [Abstract][Full Text] [Related]
7. Ataxia telangiectasia-mutated protein can regulate p53 and neuronal death independent of Chk2 in response to DNA damage.
Keramaris E; Hirao A; Slack RS; Mak TW; Park DS
J Biol Chem; 2003 Sep; 278(39):37782-9. PubMed ID: 12857758
[TBL] [Abstract][Full Text] [Related]
8. An ATM/Chk2-mediated DNA damage-responsive signaling pathway suppresses Epstein-Barr virus transformation of primary human B cells.
Nikitin PA; Yan CM; Forte E; Bocedi A; Tourigny JP; White RE; Allday MJ; Patel A; Dave SS; Kim W; Hu K; Guo J; Tainter D; Rusyn E; Luftig MA
Cell Host Microbe; 2010 Dec; 8(6):510-22. PubMed ID: 21147465
[TBL] [Abstract][Full Text] [Related]
9. Osteoblasts survive the arsenic trioxide treatment by activation of ATM-mediated pathway.
Hu YC; Hsieh BS; Cheng HL; Huang LW; Huang TC; Huang IY; Chang KL
Biochem Pharmacol; 2013 Apr; 85(7):1018-26. PubMed ID: 23337567
[TBL] [Abstract][Full Text] [Related]
10. ATM-Chk2-p53 activation prevents tumorigenesis at an expense of organ homeostasis upon Brca1 deficiency.
Cao L; Kim S; Xiao C; Wang RH; Coumoul X; Wang X; Li WM; Xu XL; De Soto JA; Takai H; Mai S; Elledge SJ; Motoyama N; Deng CX
EMBO J; 2006 May; 25(10):2167-77. PubMed ID: 16675955
[TBL] [Abstract][Full Text] [Related]
11. DNA damage-induced association of ATM with its target proteins requires a protein interaction domain in the N terminus of ATM.
Fernandes N; Sun Y; Chen S; Paul P; Shaw RJ; Cantley LC; Price BD
J Biol Chem; 2005 Apr; 280(15):15158-64. PubMed ID: 15713674
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of p53 on Ser15 during cell cycle caused by Topo I and Topo II inhibitors in relation to ATM and Chk2 activation.
Zhao H; Traganos F; Darzynkiewicz Z
Cell Cycle; 2008 Oct; 7(19):3048-55. PubMed ID: 18802408
[TBL] [Abstract][Full Text] [Related]
13. Defective p53 response and apoptosis associated with an ataxia-telangiectasia-like phenotype.
Gueven N; Becherel OJ; Birrell G; Chen P; DelSal G; Carney JP; Grattan-Smith P; Lavin MF
Cancer Res; 2006 Mar; 66(6):2907-12. PubMed ID: 16540636
[TBL] [Abstract][Full Text] [Related]
14. Defective Mre11-dependent activation of Chk2 by ataxia telangiectasia mutated in colorectal carcinoma cells in response to replication-dependent DNA double strand breaks.
Takemura H; Rao VA; Sordet O; Furuta T; Miao ZH; Meng L; Zhang H; Pommier Y
J Biol Chem; 2006 Oct; 281(41):30814-23. PubMed ID: 16905549
[TBL] [Abstract][Full Text] [Related]
15. Reoxygenation following hypoxia activates DNA-damage checkpoint signaling pathways that suppress cell-cycle progression in cultured human lymphocytes.
Kim BM; Choi JY; Kim YJ; Woo HD; Chung HW
FEBS Lett; 2007 Jun; 581(16):3005-12. PubMed ID: 17544403
[TBL] [Abstract][Full Text] [Related]
16. Activation of the phosphorylation of ATM contributes to radioresistance of glioma stem cells.
Zhou W; Sun M; Li GH; Wu YZ; Wang Y; Jin F; Zhang YY; Yang L; Wang DL
Oncol Rep; 2013 Oct; 30(4):1793-801. PubMed ID: 23846672
[TBL] [Abstract][Full Text] [Related]
17. Modification of the ATM/ATR directed DNA damage response state with aging and long after hepatocyte senescence induction in vivo.
Panda S; Isbatan A; Adami GR
Mech Ageing Dev; 2008 Jun; 129(6):332-40. PubMed ID: 18440596
[TBL] [Abstract][Full Text] [Related]
18. Induction of G2/M arrest by pseudolaric acid B is mediated by activation of the ATM signaling pathway.
Meng AG; Jiang LL
Acta Pharmacol Sin; 2009 Apr; 30(4):442-50. PubMed ID: 19305423
[TBL] [Abstract][Full Text] [Related]
19. CHEK2 genomic and proteomic analyses reveal genetic inactivation or endogenous activation across the 60 cell lines of the US National Cancer Institute.
Zoppoli G; Solier S; Reinhold WC; Liu H; Connelly JW; Monks A; Shoemaker RH; Abaan OD; Davis SR; Meltzer PS; Doroshow JH; Pommier Y
Oncogene; 2012 Jan; 31(4):403-18. PubMed ID: 21765476
[TBL] [Abstract][Full Text] [Related]
20. Indole-3-carbinol activates the ATM signaling pathway independent of DNA damage to stabilize p53 and induce G1 arrest of human mammary epithelial cells.
Brew CT; Aronchik I; Hsu JC; Sheen JH; Dickson RB; Bjeldanes LF; Firestone GL
Int J Cancer; 2006 Feb; 118(4):857-68. PubMed ID: 16152627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
